Rating History for Bristol-Myers Squibb Co. (bmy) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/19/2026 | Brandon Oglenski | New Coverage | Overweight (N/A) |
75.00 (N/A) |
59.73 (60.29) |
0.94% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||


